Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 484,968 | 1,910,657 | 1,674,413 | 1,413,864 | 1,272,286 |
| Marketable Securities | 637,439 | 937,162 | 929,736 | 686,258 | 814,129 |
| Receivables | 3,324,419 | 2,941,500 | 3,002,150 | 2,606,625 | 2,554,667 |
| Inventories | 1,891,926 | 1,701,211 | 1,658,784 | 1,692,432 | 1,698,920 |
| Other current assets | 0 | 0 | 0 | 1 | 1 |
| TOTAL | $6,338,752 | $7,490,530 | $7,265,083 | $6,399,180 | $6,340,003 |
| Non-Current Assets | |||||
| PPE Net | 4,023,948 | 3,897,184 | 3,884,112 | 3,810,775 | 3,867,510 |
| Investments And Advances | 137,591 | 98,133 | 36,230 | 35,215 | 43,035 |
| Intangibles | 309,351 | 287,632 | 298,723 | 286,102 | 277,162 |
| Other Non-Current Assets | 807,729 | 753,541 | 616,450 | 732,160 | 531,654 |
| TOTAL | $5,278,619 | $5,036,490 | $4,835,516 | $4,864,252 | $4,719,361 |
| Total Assets | $11,617,370 | $12,527,020 | $12,100,600 | $11,263,430 | $11,059,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 147,695 | 38,292 | 118,992 | 125,443 | 53,130 |
| Accounts payable and accrued liabilities | 641,113 | 728,785 | 520,546 | 508,255 | 545,291 |
| Other current liabilities | 3,599,602 | 3,151,658 | 3,037,315 | 3,061,445 | 3,568,742 |
| TOTAL | $4,849,129 | $4,314,473 | $4,557,039 | $4,453,584 | $4,538,365 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 504,073 | 511,325 | 515,395 | 472,865 | 462,231 |
| TOTAL | $599,046 | $631,008 | $594,960 | $615,302 | $534,842 |
| Total Liabilities | $5,448,175 | $4,945,481 | $5,151,999 | $5,068,886 | $5,073,207 |
| Shareholders' Equity | |||||
| Common Shares | 101,035 | 97,955 | 97,680 | 96,360 | 99,176 |
| Retained earnings | 5,945,451 | 7,326,500 | 6,716,477 | 5,979,576 | 5,757,167 |
| Other shareholders' equity | 126,711 | 161,084 | 137,443 | 120,610 | 132,814 |
| TOTAL | $6,169,197 | $7,581,539 | $6,948,600 | $6,194,546 | $5,986,157 |
| Total Liabilities And Equity | $11,617,372 | $12,527,020 | $12,100,599 | $11,263,432 | $11,059,364 |